Vidhatha Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 5.35 Cr
as on 15-12-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.15 Cr
as on 15-12-2024
About Vidhatha Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.35 Cr.
The company currently has active open charges totaling ₹19.15 Cr.
Kandula Mohan, Shireesh Kavuri, Dakarapu Rao, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TG2022PTC167874
- Company No.
167874
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vidhatha Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kandula Mohan  | Managing Director | 31-Oct-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shireesh Kavuri | Director | 31-Oct-2022 | Current |
| Dakarapu Rao | Director | 31-Oct-2022 | Current |
| Vaitla Chowdary | Director | 02-Apr-2024 | Current |
Financial Performance of Vidhatha Life Sciences.
Enhance accessibility to Vidhatha Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vidhatha Life Sciences?
Unlock access to Vidhatha Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Oct 2023 | ₹1.52 M | Open |
Hdfc Bank Limited Creation Date: 06 Feb 2023 | ₹19.00 Cr | Open |
How Many Employees Work at Vidhatha Life Sciences?
Unlock and access historical data on people associated with Vidhatha Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vidhatha Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vidhatha Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
